Smad3 reduces susceptibility to hepatocarcinoma by sensitizing hepatocytes to apoptosis through downregulation of Bcl-2
- 1 June 2006
- journal article
- research article
- Published by Elsevier in Cancer Cell
- Vol. 9 (6) , 445-457
- https://doi.org/10.1016/j.ccr.2006.04.025
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- National Cancer Institute
This publication has 69 references indexed in Scilit:
- Inactivation of TGF-β signaling in hepatocytes results in an increased proliferative response after partial hepatectomyOncogene, 2005
- Activation and signaling of the p38 MAP kinase pathwayCell Research, 2005
- Smad-dependent and Smad-independent pathways in TGF-β family signallingNature, 2003
- TGF-β induces apoptosis through Smad-mediated expression of DAP-kinaseNature Cell Biology, 2001
- Biology of transforming growth factor ? in hepatocarcinogenesisMicroscopy Research and Technique, 2001
- A-Myb Up-regulates Bcl-2 through a Cdx Binding Site in t(14;18) Lymphoma CellsPublished by Elsevier ,2000
- Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice.Proceedings of the National Academy of Sciences, 1996
- Reduced Growth Capacity of Hepatocytes from c-myc and c-myc/TGF-α Transgenic Mice in Primary CultureBiochemical and Biophysical Research Communications, 1996
- Transforming growth factor-β receptors type I, II and III in phenobarbital-promoted rat liver tumorsCarcinogenesis: Integrative Cancer Research, 1994
- ALTERED HEPATIC FOCI: Their Role in Murine HepatocarcinogenesisAnnual Review of Pharmacology and Toxicology, 1990